Overview
A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population
Eligibility
Inclusion Criteria:
- ≥18 years of age
- Prior to first opioid prescription
- Being considered for first oral opioid prescription (4-30 days)
- Prescribed AvertD as part of care
- Willing and able to complete yearly assessments for 5 years
- Signed informed consent
Exclusion Criteria:
- Planned opioid prescription <4 or >30 days
- Any condition making participation unsafe or infeasible per investigator judgment